SCH772984 is a novel and selective inhibitor of ERK1/2 that displays behaviors of both type I and type II kinase inhibitors. SCH772984 has nanomolar cellular potency in tumor cells with mutations in BRAF, NRAS, or KRAS. SCH772984 effectively inhibited MAPK signaling and cell proliferation in BRAF or MEK inhibitor-resistant models as well as in tumor cells resistant to concurrent treatment with BRAF and MEK inhibitors. SCH772984 induces tumor regressions in xenograft models at tolerated doses.
Cancer Immunol Res. 2020 Oct;8(10):1273-1286.
An IL6-Adenosine Positive Feedback Loop between CD73 + γδTregs and CAFs Promotes Tumor Progression in Human Breast Cancer
SCH772984 purchased from AbMole
Onco Targets Ther. 2020 Jul 31;13:7585-7598.
JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells
SCH772984 purchased from AbMole
Acta Pharmacol Sin. 2019 Dec 17.
Acid sphingomyelinase downregulation alleviates vascular endothelial leptin resistance in rats.
SCH772984 purchased from AbMole
Cell. 2019 Mar 7;176(6):1379-1392.e14.
Lateral Inhibition in Cell Specification Mediated by Mechanical Signals Modulating TAZ Activity.
SCH772984 purchased from AbMole
J Neurosci 2018 Mar 26.
HIPK2-mediated transcriptional control of NMDA receptor subunit expression regulates neuronal survival and cell death
SCH772984 purchased from AbMole
Saudi Pharmaceutical Journal. 2016 May;24(3):354-62.
Analgesic effect and possible mechanism of SCH772984 intrathecal injection on rats with bone cancer pain.
SCH772984 purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | BRAF- or RAS-mutant tumor cells |
Preparation method | Cell proliferation experiments were carried out in a 96-well format (six replicates), and cells were plated at a density of 4,000 cells per well. At 24 hours after cell seeding, cells were treated with DMSO or a 9-point IC50 dilution (0.001–10 μmol/L) at a final concentration of 1% DMSO for all concentrations. Viability was assayed 5 days after dosing using the ViaLight luminescence kit (Lonza) following the manufacturer's recommendations (n = 6, mean ± SE). For the cell line panel viability assay, cells were treated with SCH772984 for 4 days and assayed by the CellTiterGlo luminescent cell viability assay (Promega). |
Concentrations | 0.001–10 μmol/L |
Incubation time | 4 days |
Animal Experiment | |
---|---|
Animal models | Female nude mice bearing human LOX BRAF-mutant/MiaPaCa KRAS-mutant pancreatic/ melanoma xenograft model |
Formulation | normal saline |
Dosages | 12.5, 25, or 50 mg/kg for 14 days |
Administration | intraperitoneally |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Molecular Weight | 587.67 |
Formula | C33H33N9O2 |
CAS Number | 942183-80-4 |
Purity | 100.00% |
Solubility | DMSO 12 mg/mL warming |
Storage | at -20°C |
Related ERK Products |
---|
2,5-Dihydroxyacetophenone
2',5'-Dihydroxyacetophenone (DHAP, 2-Acetylhydroquinone, Quinacetophenone) is a mixture of dihydroxyacetophenone isomers used in food flavoring. 2',5'-Dihydroxyacetophenone significantly inhibits the production of NO by inhibiting the expression of iNOS. 2',5'-Dihydroxyacetophenone significantly reduces the expression levels of the pro-inflammatory cytokines TNF-α and IL-6 by blocking the ERK1/2 and NF-κB signaling pathways. |
Tenuifoliside A
Tenuifoliside A is isolated from Yuanzhi and has anti-apoptotic and antidepressant effects. In C6 cells, Tenuifoliside A exhibits its neurotrophic effects and promotes cell proliferation through the ERK/CREB/BDNF signaling pathway. |
Tauroursodeoxycholate dihydrate
Tauroursodeoxycholate (Tauroursodeoxycholic acid; TDUCA) dihydrate is an endoplasmic reticulum stress inhibitor. Tauroursodeoxycholate significantly reduces the expression of apoptotic molecules such as caspase-3 and caspase-12. Tauroursodeoxycholate also suppresses ERK. |
DMU-212
DMU-212 is a resveratrol methylated derivative with anti-division, antiproliferative, antioxidant and apoptosis-promoting activities. DMU-212 causes mitosis to stop by inducing apoptosis and activating the ERK1/2 protein. |
(rel)-AR234960
(rel)-AR234960 is the relatively active configuration of AR234960. AR234960 is a non-peptide MAS (a G protein coupling receptor) agonist that upregulates CTGF mRNA and protein levels through the ERK1/2 signaling pathway in HEK293-MAS cells and adult myocardial fibroblasts. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.